Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Change in Accured Expenses (2017 - 2025)

Cue Biopharma (CUE) has disclosed Change in Accured Expenses for 9 consecutive years, with -$259000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 11.0% to -$259000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.3 million through Dec 2025, down 5.53% year-over-year, with the annual reading at -$1.3 million for FY2025, 5.53% down from the prior year.
  • Change in Accured Expenses hit -$259000.0 in Q4 2025 for Cue Biopharma, down from $352000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q3 2021 to a low of -$2.7 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged -$58812.4 across 5 years, with a median of -$116000.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: soared 703.92% in 2023 and later plummeted 320.47% in 2025.
  • Year by year, Change in Accured Expenses stood at $630752.0 in 2021, then crashed by 152.32% to -$330000.0 in 2022, then plummeted by 198.48% to -$985000.0 in 2023, then soared by 70.46% to -$291000.0 in 2024, then increased by 11.0% to -$259000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for CUE at -$259000.0 in Q4 2025, $352000.0 in Q3 2025, and -$2.7 million in Q2 2025.